AU1811397A - Imidazole derivatives and vascular wall thickening inhibitor - Google Patents

Imidazole derivatives and vascular wall thickening inhibitor

Info

Publication number
AU1811397A
AU1811397A AU18113/97A AU1811397A AU1811397A AU 1811397 A AU1811397 A AU 1811397A AU 18113/97 A AU18113/97 A AU 18113/97A AU 1811397 A AU1811397 A AU 1811397A AU 1811397 A AU1811397 A AU 1811397A
Authority
AU
Australia
Prior art keywords
vascular wall
imidazole derivatives
wall thickening
thickening inhibitor
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18113/97A
Inventor
Hiromu Harada
Yukihiko Hotei
Koji Kamata
Kiyoshi Kasai
Hiroshi Kusama
Yoshinori Nonaka
Toshikazu Yazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of AU1811397A publication Critical patent/AU1811397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
AU18113/97A 1996-02-29 1997-02-26 Imidazole derivatives and vascular wall thickening inhibitor Abandoned AU1811397A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP8-82966 1996-02-29
JP8296696 1996-02-29
JP8-354238 1996-11-28
JP8-354237 1996-11-28
JP35423896 1996-11-28
JP35423796 1996-11-28
PCT/JP1997/000533 WO1997031900A1 (en) 1996-02-29 1997-02-26 Imidazole derivatives and vascular wall thickening inhibitor

Publications (1)

Publication Number Publication Date
AU1811397A true AU1811397A (en) 1997-09-16

Family

ID=27304065

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18113/97A Abandoned AU1811397A (en) 1996-02-29 1997-02-26 Imidazole derivatives and vascular wall thickening inhibitor

Country Status (2)

Country Link
AU (1) AU1811397A (en)
WO (1) WO1997031900A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6748498A (en) * 1997-04-15 1998-11-11 Kissei Pharmaceutical Co. Ltd. 2-substituted carbamoylimidazolecarboxylic acid derivatives and vascular-wall thickening inhibitor
EP1229010A1 (en) * 1999-10-01 2002-08-07 Japan Energy Corporation Novel diarylamide derivatives and use thereof as medicines
US6888014B2 (en) * 2001-07-24 2005-05-03 Panagin Pharmaceuticals Inc. Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
SE0401653D0 (en) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
FR2889190A1 (en) * 2005-08-01 2007-02-02 Merck Sante Soc Par Actions Si New imidazole carboxamides, useful to treat e.g. pathologies associated with the insulin resistance syndrome, are fructose-1,6-biphosphatase inhibitors
AU2006327317B2 (en) 2005-12-23 2010-11-25 Astrazeneca Ab GABA-B receptor modulators
JP2009521428A (en) 2005-12-23 2009-06-04 アストラゼネカ・アクチエボラーグ Imidazole derivatives for the treatment of gastrointestinal diseases
EP2179984A1 (en) * 2008-10-27 2010-04-28 Congenia S.r.l. Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
US10959987B2 (en) 2019-04-15 2021-03-30 King Abdulaziz University Imidazole-based compounds as hepatitis C virus inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04154720A (en) * 1990-10-16 1992-05-27 Terumo Corp Catechol derivative and vascular hypertrophy-preventive agent containing the same derivative
DE4325822A1 (en) * 1993-07-31 1995-02-02 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
DE4328869A1 (en) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them

Also Published As

Publication number Publication date
WO1997031900A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
AU4383397A (en) Hetaroyl derivatives
AU4554297A (en) Hetaroyl derivatives
AU1844497A (en) Inhibitors of farnesyl-protein transferase
AU2593097A (en) Inhibitors of farnesyl-protein transferase
AU2253097A (en) Inhibitors of farnesyl-protein transferase
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
AU2430197A (en) Inhibitors of farnesyl-protein transferase
AU2555997A (en) Inhibitors of farnesyl-protein transferase
AU2598897A (en) Inhibitors of farnesyl-protein transferase
AU5410498A (en) Pyrazole derivatives
AU2552497A (en) Inhibitors of farnesyl-protein transferase
AU2440297A (en) Thin-walled and braid-reinforced catheter
AU5599598A (en) Inhibitors of glycosyltransferases
AU1851697A (en) Inhibitors of farnesyl-protein transferase
AU2361897A (en) Corrosion inhibitor
AU2587597A (en) Inhibitors of farnesyl-protein transferase
AU3673497A (en) Detection of microbacteria
AU2432597A (en) Inhibitors of farnesyl-protein transferase
AU2432697A (en) Inhibitors of farnesyl-protein transferase
AU2430397A (en) Inhibitors of farnesyl-protein transferase
AU1811397A (en) Imidazole derivatives and vascular wall thickening inhibitor
AU3551297A (en) Polymerisation inhibitor
AU2554897A (en) Inhibitors of farnesyl-protein transferase
AU2600597A (en) Inhibitors of farnesyl-protein transferase
AU2593297A (en) Inhibitors of farnesyl-protein transferase